Clinical Trial Update: Clinical Control Study of Immunotherapy and Concurrent Chemoradiotherapy in Patients With Esophageal Cancer Recurrence [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating immunotherapy with concurrent chemoradiotherapy for esophageal cancer local recurrence; status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Esophageal Malignant Neoplasm

Snippet

Sponsor: The First Affiliated Hospital of Henan University of Science and Technology | Conditions: Esophageal Malignant Neoplasm, Local Recurrence | Phase 3 | Status: UNKNOWN